Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
abstract reasoning
activities of daily living scale
advances in neurology
adverse drug reaction
aggression
agitation
agnosia, visual
alexia
algorithm
Alzheimer's disease
Alzheimer's disease, behavioral symptoms
Alzheimer's disease, diagnosis of
Alzheimer's disease, driving with
Alzheimer's disease, early symptoms
Alzheimer's disease, familial
Alzheimer's disease, noncognitive symptoms
Alzheimer's disease, preclinical
Alzheimer's disease, risk factors in
Alzheimer's disease, treatment of
Alzheimer's disease, visual variant
amyloid
amyloid beta protein
amyloid deposition
amyloid imaging
amyloid plaques
aneurysm, intracranial, familial
anomic aphasia
anticholinesterase
antidepressant
anxiety
aphasia
aphasia, progressive
aphasia, progressive, primary
apolipoprotein E
asymptomatic
attention span
behavior
behavior, combative
behavioral disorder
biologic markers
brain atrophy
caregiver
CAT scan
CAT scan, abnormal
CAT scan, emission
CAT scan, emission, abnormal
cerebral cortical atrophy
cerebral dominance
cerebrospinal fluid, biochemical markers of CNS disease
cerebrovascular accident
cerebrovascular accident, multiple
chronic fatigue syndrome
cognition
competency
comprehension, impaired
degenerative diseases of CNS
delay in diagnosis
delusion
dementia
dementia, cerebrovascular disease causing
dementia, clinical diagnosis
dementia, diagnostic evaluation of
dementia, differential diagnosis of
dementia, early detection
dementia, familial
dementia, screening for
dementia, treatment of
depression
depth perception, impaired
dextromethorphan
diagnostic criteria
draw a clock
drawing
driving
dyslexia
evidence-based research
exercise
familial
fatigue
frontal lobe, behavior with disease of
frontal lobe, lesion of
genetic testing
head injury
hemianopia
hemianopia, homonymous
heralding manifestation
hippocampus
hoarding
inappropriate behavior
informed consent
intellectual deficit
judgement, impaired
language disorder in adults
lobar atrophy
logopenia
memantine
Memory Impairment Screen
memory, impairment of
memory, impairment of, subjective
mental status, evaluation of
mild cognitive impairment
mild cognitive impairment converting to Alzheimer's disease
Mini Mental Status Examination
misdiagnosis
MRI
MRI, abnormal
MRI, false negative
MRI, negative
MRI, volumetry
neuroleptic
neuroleptic, atypical
neurologic disease, diagnoses of
neurologic evaluation
neuroophthalmology
neuropathology
normal
olanzapine
old age, neurology of
orthostatic hypotension
personality change
Pittsburgh Compound B
practice guidelines
preclinical
prognosis
psychiatric problems in neurologic disorders
psychological testing
psychomotor retardation
quality of life
quinidine
reading
reading disorder, acquired
reading problem, causes of
repetitive questioning
review article
risk factors
risk factors, modification
risperidone
rummaging
self-confidence
shadowing
simultanagnosia
single photon emission computed tomography
sleep pathology and physiology
speech disorder
speech, loss of
stereotyped behavior
systemic exertion intolerance disease
treatment of neurologic disorder
treatment, non-pharmacologic
undiagnosed
visual acuity, decreased
visual field defect
visual impairment
visual symptoms
visuospatial disturbance
wandering
word-finding difficulty
Showing articles 50 to 100 of 2292 << Previous Next >>

Insular Seizures Causing Sleep-Related Breathlessness
Lancet 382:1759, Nesbitt, A.D.,et al, 2013

Predicting Alzheimer Disease with �-Amyloid Imaging: Results from the Australian Imaging, Biomarkers, and Lifestyle Study of Ageing
Ann Neurol 74:905-913, Rowe, C.C.,et al, 2013

Criteria for the Diagnosis of Corticobasal Degeneration
Neurol 80:496-503, Armstrong, M.J.,et al, 2013

Frontotemporal Dementia
BMJ 347:f4827, Warren, J.D.,et al, 2013

Lifelong Management of Amyloid-Beta Metabolism to Prevent Alzheimers Disease
NEJM 367:864-866, Gandy, S., 2012

Clinical and Biomarker Changes in Dominantly Inherited Alzheimers Disease
NEJM 367:795-804,864, Bateman, R.J.,et al, 2012

Rapidly Progressive Alzheimer Disease
Arch Neurol 68:1124-1130, Schmidt, C.,et al, 2011

Computerized Visual Field Defects in Posterior Cortical Atrophy
Neurol 77:2119-2122, Pelak, V.S.,et al, 2011

Longitudinal Assessment of A-beta and Cognition in Aging and Alzheimer Disease
Ann Neurol 69:181-192, Villemagne,V.L.,et al, 2011

Classification of Primary Progressive Aphasia and Its Variants
Neurol 76:1009-1014, Gorno-Tempini,M.L.,et al, 2011

Autoimmune encephalitis
BMJ 342:d1918, Irani, S.R.,et all, 2011

Changing Concepts of Alzheimer Disease
JAMA 35:2458-2459, McKhann, G.M., 2011

Sleep-Disordered Breathing, Hypoxia, and Risk of Mild Cognitive Impairment and Dementia in Older Women
JAMA 306(6):613-619, Yaffe, K.,et al, 2011

Practice Parameter Update: Evaluation and Management of Driving Risk in Dementia: Report of the Quality Standards Subcommittee of the American Academy of Neurology
Neurol 74:1316-1324, Iverson,D.J., et al, 2010

Serial MRI and CSF Biomarkers in Normal Aging, MCI, and AD
Neurol 75:143-151, Vemuri,P., et al, 2010

Early Alzheimers Disease
NEJM 362:2194-2201, Mayeux,R., 2010

Neurosacrcoidosis: Presentations and Management
Neurologist 16:2-15, Terushkin,V.,et al, 2010

CNS Complications of Radiotherapy and Chemotherapy
Lancet 374:1639-1651, Soussain,C.,et al, 2009

Conversion of Amyloid Positive and Negative MCI to AD over 3 Years: An 11C-PIB PET Study
Neurol 73:754-760, 744, Okello,A.,et al, 2009

Clinical Syndromes Associated with Posterior Atrophy: Early Age at Onset AD Spectrum
Neurol 73:1571-1578, Migliaccio,R.,et al, 2009

Clinicopath Conf, Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL)
NEJM 360:1656-1665, Case 12-2009, 2009

Donepezil Treatment of Patients with MCI: A 48-Week Randomized, Placebo-Controlled Trial
Neurol 72:1555-1561, Doody,R.S.,et al, 2009

CSF Biomarkers and Incipient Alzheimer Disease in Patients with Mild Cognitive Impairment
JAMA 302:385-393,436,452, Mattsson,N.,et al, 2009

Association Between Mid-Life Martial Status and Cognitive Function in Later Life: Population Based Cohort Study
BMJ 339:99,57, H�kansson,K.,et al, 2009

Disclosure of APOE Genotype for Risk of Alzheimers Disease
NEJM 361:245-254,298, Green,R.C.,et al, 2009

A 60-Year-Old Woman with Mild Memory Impairment: Review of Mild Cognitive Impairment
JAMA 300:1566-1574,1598, Ellison,J.M., 2008

Medical Decision-Making Capacity in Mild Cognitive Impairment: A 3-Year Longitudinal Study
Neurol 71:1474-1480, Okonkwo,O.C.,et al, 2008

Effect of Demebon on Cognition, Activities of Daily Living, Behavior, and Global Function in Patients With Mild-To-Moderate Alzheimers Disease: A Randomised, Double-Blind, Placebo-Controlled Study
Lancet 372:207-215,179, Doody, R.S.,et al., 2008

Biochemical Markers in Persons With Preclinical Familial Alzheimer Disease
Neurol 71:85-92,78, Ringman,J.M.,et al., 2008

Foreign Accent Syndrome as the Initial Sign of Primary Progressive Aphasia
JNNP 79:79-81, Luzzi,S.,et al, 2008

Disease-Modifying Therapies for Alzheimer Disease: Challenges to Early Intervention
Neurol 69:1622-1634, Cummings,J.L.,et al, 2007

Primary Central Nervous System Vasculitis: Analysis of 101 Patients
Ann Neurol 62:442-451,430, Salvarani,C.,et al, 2007

The Neuroprotective Effects of Caffeine: A Prospective Population Study (the Three City Study)
Neurol 69:536-545, Ritchie,K.,et al, 2007

Donepezil Preserves Cognition and Global Function in Patients With Severe Alzheimer Disease
Neurol 69:459-469, Black,S.E.,et al, 2007

A Review of Screening Tests for Cognitive Impairment
JNNP 78:790-799, Cullen,B.,et al, 2007

First Symptom in Sporadic Creutzfeldt-Jakob Disease
Neurol 66:286-287, Rabinovici,G.D.,et al, 2006

Bone Mineral Density and the Risk of Alzheimer Disease
Arch Neurol 62:107-111, Tan,Z.S.,et al, 2005

A 32-Year Prospective Study of Change in Body Weight and Incident Dementia
Arch Neurol 62:55-60,20, Stewart,R.,et al, 2005

Neurologic Manifestations in Welders with Pallidal MRI T1 Hyperintensity
Neurol 64:2033-2039,2001, Josephs,K.A.,et al, 2005

A 10-Item Smell Identification Scale Related to Risk for Alzheimers Disease
Ann Neurol 58:155-160, Taberr,M.H.,et al, 2005

Pharmacological treatment of Neuropsychiatric Symptoms of Dementia
JAMA 293:596-608, Sink,K.M.,et al, 2005

Lipid Lowering Agents Are Associated With a Slower Cognitive Decline in Alzheimers Disease
JNNP 76:1624-1629, Masse,I.,et al, 2005

A Multimodal Assessment of Driving Performance in HIV Infection
Neurol 63:1417-1422, Marcotte,T.D.,et al, 2004

Potentially Reversible Autoimmune Limbic ncephalitis with Neuronal Potassium Channel Antibody
Neurol 62:1177-1182,1040, Thieben,M.J.,et al, 2004

Long-term Donepezil Treatment in 565 Patients with Alzheimer's Disease (AD2000): Randomised Double-Blind Trial
Lancet 363:2105-2115,2100, AD2000 Collaborative Group, 2004

Conjugated Equine Estrogens and Incidence of Probable Dementia and Mild Cognitive Impairment in Postmenopausal Women
JAMA 291:2947-2958,3005, Shumaker,S.A.,et al, 2004

Primary Progressive Aphasia--A Language-Based Dementia
NEJM 349:1535-1542, Mesulam,M.-M., 2003

Neuroimaging and Early Diagnosis of Alzheimer Disease: A Look to the Future
Radiology 226:315-336, Petrella,J.R.,et al, 2003

The Outcome of Neurology Outpatients with Medically Unexplained Symptoms: A Prospective Cohort Study
JNNP 74:897-900,842, Carson,A.J.,et al, 2003

Estrogen Plus Progestin and the Incidence of Dementia and Mild Cognitive Impairment in Postmenopausal Women
JAMA 289:2651-2662,2717, Shumaker,S.A.,et al, 2003



Showing articles 50 to 100 of 2292 << Previous Next >>